Search contract descriptions, companies and agencies.
ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM
Total Committed
$13.4M
Product or Service Description
Ships R&D Defense System (Advanced Development)
Total Potential Value
$26.7M
Contracting Agency
Effective Date
Oct. 5, 2020
Funding Department
DEFENSE THREAT REDUCTION AGENCY
Type
Cost plus fixed fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| INTERNATIONAL AIDS VACCINE INITATIVE INC. | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | Dec. 23, 2020 | Funding Only Action | $1,065,291 |
| INTERNATIONAL AIDS VACCINE INITATIVE INC. | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | Dec. 7, 2020 | Funding Only Action | $5,843,608 |
| INTERNATIONAL AIDS VACCINE INITATIVE INC. | ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | Oct. 5, 2020 | $6,456,392 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.